Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Prospective, Randomized Controlled Clinical Trial of Glutathione Combined With PD-1 Antibody and Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06896422
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:29.789580+00:00
Published At
2025-08-07T00:00:00+00:00
Record Updated At
2025-08-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-Small Cell Lung Cancer", "Chemotherapy", "PD1 Antibody", "Glutathione"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-07"
protocolSection.identificationModule.nctId
"NCT06896422"
protocolSection.identificationModule.officialTitle
"Prospective, Randomized Controlled Clinical Trial of Glutathione Combined With PD-1 Antibody and Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Chemotherapy (protocolSection.conditionsModule.conditions)
  • PD1 Antibody (protocolSection.conditionsModule.conditions)
  • Glutathione (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.